clinical trial diversity

Technologys Role in the Patient Experience

Technology’s Role in the Patient Experience

Healthcare and technology have always gone hand-in-hand. In fact, some of medicine’s earliest innovations are the most enduring. For clinical trials, the convergence of healthcare and technology creates a constant stream of innovation in the pursuit of novel treatments and therapies. Likewise, the pandemic and subsequent growth of decentralized trials demonstrate how technology can play an essential role in the patient experience.

Technology’s Role in the Patient Experience Read More »

SCRS Talks How the Clinical Treatment Act is Increasing Diverse Access to Trials

SCRS Talks Podcast: How the Clinical Treatment Act is Increasing Diverse Access to Trials

In January 2022, the U.S. enacted legislation supporting our industry’s ability to sponsor more diverse, equitable, and inclusive clinical trials via the Clinical Treatment Act.  This law aims to create equal and increased access to clinical trials for more than 76 million Americans enrolled in Medicaid. SCRS sat down with Scott Gray, CEO of Clincierge,

SCRS Talks Podcast: How the Clinical Treatment Act is Increasing Diverse Access to Trials Read More »

Medicaid Mandate 2022: Striving for Equitable Access to Clinical Trials

Medicaid Mandate 2022: Striving for Equitable Access to Clinical Trials

Featured in Pharmaceutical Outsourcing, Scott Gray, CEO discusses changes to the Medicaid program and the impact it has on clinical trial participation. On Jan. 1, 2022, coverage of all “routine costs” associated with clinical trial participation became guaranteed for Medicaid beneficiaries through the Clinical Treatment Act. For clinical trial sponsors and clinical research organizations (CROs),

Medicaid Mandate 2022: Striving for Equitable Access to Clinical Trials Read More »

Caring for rare: Celebrating Rare Disease Day 2023

Enhancing Patient Access and Retention in Rare Disease Clinical Trials

Featured in an article in PM360, Scott Gray, CEO, discusses new developments in the rare disease clinical trial industry ahead of the upcoming Rare Disease Day on February 28, 2022. Learn more about alleviating financial barriers to trial participation, mitigating geographical barriers to trial participation, and the federal efforts to support rare disease trials in

Enhancing Patient Access and Retention in Rare Disease Clinical Trials Read More »

Medicaid clinical trials routine costs

Medicaid Coverage of “Routine Costs” for Clinical Trials

Featured in Applied Clinical Trials, Scott Gray, CEO discusses changes to the Medicaid program and the impact it has on clinical trial participation. On Jan. 1, 2022, coverage of all “routine costs” associated with clinical trial participation became guaranteed for Medicaid beneficiaries through the Clinical Treatment Act. For clinical trial sponsors and clinical research organizations

Medicaid Coverage of “Routine Costs” for Clinical Trials Read More »

Improving Access Pediatric Clinical Trial Participation

Improving Access for Pediatric Clinical Trial Participation

Featured in the winter edition of the SCRS InSite Journal, Scott Gray, CEO, discusses industry-wide challenges and key ways to alleviate emotional, financial, and logistical burdens to improve clinical trial access for pediatric patients and their caregivers. Alleviating burdens can boost trial recruitment, enhance the patient experience, and increase patient retention.

Improving Access for Pediatric Clinical Trial Participation Read More »

Practical Approach to Clinical Trial Diversity

A Practical Approach to Clinical Trial Diversity

In an article featured in BioProcess International, Scott Gray, CEO, discusses a practical approach to achieving inclusive representation in clinical studies. Life-science companies can attract large, diverse participant pools by reaching patients where they live, providing targeted and meaningful messaging about the benefits of trials and offering ongoing assistance.

A Practical Approach to Clinical Trial Diversity Read More »

patient as partners improve clinical trial diversity

Patient Engagement: The Key to Improving Diversity in Clinical Trials

In the Fall issue of the Patients as Partners Newsletter, Scott Gray, CEO discusses the key benefits of engaging patients to improve diversity in clinical trials. When clinical trial stakeholders engage patients they can overcome barriers to participation and alleviate patient uncertainty which improves patients’ experiences and increases retention.

Patient Engagement: The Key to Improving Diversity in Clinical Trials Read More »

error: Protected content.

Clincierge is now a Greenphire company!